On behalf of the National Forum for Heart Disease and Stroke Prevention, Executive Director John Clymer recently presented comments to the Centers for Medicare and Medicaid Services (CMS) during a town hall on Medicare drug price negotiation for Tradjenta (linagliptin). Clymer urged CMS to protect access to Tradjenta by emphasizing its distinct …
National Forum Urges OMB to Expand Access to Anti-Obesity Therapies
The National Forum for Heart Disease and Stroke Prevention presented comments to the Office of Management and Budget in support of expanding Medicare coverage for anti-obesity medications (AOMs). John Clymer, executive director of the National Forum, emphasized that obesity is a complex, chronic disease and urged policymakers to treat it as …
National Forum and Partners Call for Policy Changes to Expand Access to Pharmacist Care
Recommendations highlight the role of pharmacists in expanding access to care Washington, D.C. – The National Forum for Heart Disease and Stroke Prevention and a coalition of 14 organizations are urging policymakers to expand access to healthcare by fully utilizing pharmacists as integral members of the care team. In a joint policy …
National Forum Releases Policy Statement on Achieving Health, Fair Access to Care
Recommendations highlight the role of community health workers in bridging gaps in care Washington, D.C. – The National Forum for Heart Disease and Stroke Prevention and a coalition of 13 groups have issued a joint policy statement to promote health and fair access to care. The statement provides actionable recommendations for fully …
VAC Calls for Transparency in PBM Industry
Value and Access Collaborative (VAC) Recommends Congress Reform PBM Practices The National Forum highlights the VAC’s recommendations as Congress considers legislation to regulate PBMs. In letters to House Oversight and Accountability Committee leaders, who met Tuesday to markup one such bill, National Forum executive director John Clymer …
National Forum ED Addresses CMS on Medicare Drug Price Negotiation Patient-Focused Listening Session for Farxiga
Today, on behalf of the National Forum, Executive Director John Clymer presented comments to the Centers for Medicare and Medicaid Services Listening Session on Medicare Drug Price Negotiation for Eliquis. Clymer urged CMS to ensure the Medicare Drug Price Negotiation Program: • supports evidence-based strategies for appropriate care, and protects …
National Forum ED Addresses CMS on Medicare Drug Price Negotiation Patient-Focused Listening Session for Entresto
Today, on behalf of the National Forum, Executive Director John Clymer presented comments to the Centers for Medicare and Medicaid Services Listening Session on Medicare Drug Price Negotiation for Eliquis. Clymer urged CMS to ensure the Medicare Drug Price Negotiation Program: • supports evidence-based strategies for appropriate care, and protects …
National Forum ED Addresses CMS on Medicare Drug Price Negotiation Patient-Focused Listening Session for Eliquis
Today, on behalf of the National Forum, Executive Director John Clymer presented comments to the Centers for Medicare and Medicaid Services Listening Session on Medicare Drug Price Negotiation for Eliquis. Clymer urged CMS to ensure the Medicare Drug Price Negotiation Program: • supports evidence-based strategies for appropriate care, and protects …
Value & Access Collaboration Submits Comments to FTC on PBM Business Practices
The Value & Access Collaboration, convened by the National Forum for Heart Disease & Stroke Prevention, responded to the Federal Trade Commission (FTC)’s Request for Information about how large, vertically integrated pharmacy benefits managers’ (PBMs’) business practices affect consumers’ access to healthcare. Twenty-one organizations …
